[go: up one dir, main page]

AU2013204155B2 - Pure erlotinib - Google Patents

Pure erlotinib

Info

Publication number
AU2013204155B2
AU2013204155B2 AU2013204155A AU2013204155A AU2013204155B2 AU 2013204155 B2 AU2013204155 B2 AU 2013204155B2 AU 2013204155 A AU2013204155 A AU 2013204155A AU 2013204155 A AU2013204155 A AU 2013204155A AU 2013204155 B2 AU2013204155 B2 AU 2013204155B2
Authority
AU
Australia
Prior art keywords
erlotinib
polymorphs
salts
pure
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013204155A
Other versions
AU2013204155A1 (en
Inventor
Vinayak Govind Gore
Madhav Jadhav
Anilkumar Tripathi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011298167A external-priority patent/AU2011298167B2/en
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Priority to AU2013204155A priority Critical patent/AU2013204155B2/en
Publication of AU2013204155A1 publication Critical patent/AU2013204155A1/en
Application granted granted Critical
Publication of AU2013204155B2 publication Critical patent/AU2013204155B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PURE ERLOTINIB The present invention relates to processes for the preparation of erlotinib and salts and polymorphs thereof, preferably of high purity. The present invention also relates to erlotinib and salts and polymorphs thereof preparable by said processes, to medical uses of said erlotinib, salts and polymorphs, and to pharmaceutical compositions comprising the same.
AU2013204155A 2010-07-23 2013-04-12 Pure erlotinib Ceased AU2013204155B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013204155A AU2013204155B2 (en) 2010-07-23 2013-04-12 Pure erlotinib

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2112/MUM/2010 2010-07-23
AU2011298167A AU2011298167B2 (en) 2010-07-23 2011-07-22 Pure erlotinib
AU2013204155A AU2013204155B2 (en) 2010-07-23 2013-04-12 Pure erlotinib

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2011298167A Division AU2011298167B2 (en) 2010-07-23 2011-07-22 Pure erlotinib

Publications (2)

Publication Number Publication Date
AU2013204155A1 AU2013204155A1 (en) 2013-05-02
AU2013204155B2 true AU2013204155B2 (en) 2016-07-14

Family

ID=48446908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013204155A Ceased AU2013204155B2 (en) 2010-07-23 2013-04-12 Pure erlotinib

Country Status (1)

Country Link
AU (1) AU2013204155B2 (en)

Also Published As

Publication number Publication date
AU2013204155A1 (en) 2013-05-02
AU2013204145A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
AU2013261267A8 (en) Carboxylic acid compounds
MX2011008864A (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products.
PH12013500473A1 (en) Triazine-oxadiazoles
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
GEP20217235B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
IN2014CN04530A (en)
WO2012068234A3 (en) Antiviral compounds
MD20150091A2 (en) Anti-viral compounds
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
WO2010092090A3 (en) Novel salts of sitagliptin
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
MY183312A (en) Pharmaceutical formulation
PH12015500376A1 (en) Novel bicyclic pyridinones
IN2012DN03182A (en)
IN2012DN02139A (en)
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
WO2010139981A3 (en) Processes for preparing crystalline forms of dasatinib
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
IN2012DN01292A (en)
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2014004688A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids.
MX2013009386A (en) New azaspirodecanone compounds.
WO2012015687A3 (en) Drug-ligand conjugates, synthesis thereof, and intermediates thereto

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired